These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 12137417)

  • 1. Antisense DNAs as targeted therapeutics for cancer: no longer a dream.
    Cho-Chung YS
    Curr Opin Investig Drugs; 2002 Jun; 3(6):934-9. PubMed ID: 12137417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antisense DNAs as targeted genetic medicine to treat cancer.
    Cho-Chung YS
    Arch Pharm Res; 2003 Mar; 26(3):183-91. PubMed ID: 12723929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Basics of antisense oligonucleotide therapy and current therapeutical strategies in urology].
    Kausch I; Böhle A
    Aktuelle Urol; 2003 Dec; 34(7):458-68. PubMed ID: 14655082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antisense oligonucleotides as therapeutic agents.
    Galderisi U; Cascino A; Giordano A
    J Cell Physiol; 1999 Nov; 181(2):251-7. PubMed ID: 10497304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AEG-35156, an antisense oligonucleotide against X-linked inhibitor of apoptosis for the potential treatment of cancer.
    Tamm I
    Curr Opin Investig Drugs; 2008 Jun; 9(6):638-46. PubMed ID: 18516763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential roles of antisense technology in cancer chemotherapy.
    Crooke ST
    Oncogene; 2000 Dec; 19(56):6651-9. PubMed ID: 11426651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antisense targeting in neurology].
    Tellería-Díaz A
    Rev Neurol; 2000 Oct 16-31; 31(8):762-9. PubMed ID: 11082887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antisense tumor therapy (a dream under construction).
    Kopper L; Kovalszky I
    In Vivo; 1994; 8(5):781-6. PubMed ID: 7727725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug evaluation: OGX-011, a clusterin-inhibiting antisense oligonucleotide.
    Schmitz G
    Curr Opin Mol Ther; 2006 Dec; 8(6):547-54. PubMed ID: 17243491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Technology evaluation: CpG-7909, Coley.
    Paul S
    Curr Opin Mol Ther; 2003 Oct; 5(5):553-9. PubMed ID: 14601526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antisense oligonucleotides are clinically tested. They inhibit the expression of disease-related genes].
    Sommer W; Heilig M
    Lakartidningen; 1999 Jan; 96(4):348-54. PubMed ID: 10024826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The manufacture and molecular characterization of phosphorothioate deoxynucleotides for use as antisense therapeutics in human clinical trials.
    Bergot BJ; Foy M; Hansen C; Fearon K; Frediani J; Hirschbein B
    Nucleic Acids Symp Ser; 1993; (29):57. PubMed ID: 8247794
    [No Abstract]   [Full Text] [Related]  

  • 13. Nucleic acid therapeutics: a work in progress.
    Opalinska JB; Gewirtz AM
    Curr Opin Investig Drugs; 2002 Jun; 3(6):928-33. PubMed ID: 12137416
    [No Abstract]   [Full Text] [Related]  

  • 14. The clinical experience of antisense therapy to ICAM-1 in Crohn's disease.
    Yacyshyn B; Bowen-Yacyshyn MB; Shanahan W
    Curr Opin Mol Ther; 1999 Jun; 1(3):332-5. PubMed ID: 11713798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Methodological approaches of clinical studies with targeted therapies].
    Penel N; Saleron J; Lansiaux A; Clisant S; Adenis A; Fournier C; Duhamel A; Bonneterre J
    Bull Cancer; 2008 Feb; 95(2):185-90. PubMed ID: 18304903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antisense oligodeoxynucleotide therapy targeting clusterin gene for prostate cancer: Vancouver experience from discovery to clinic.
    Miyake H; Hara I; Gleave ME
    Int J Urol; 2005 Sep; 12(9):785-94. PubMed ID: 16201973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antisense molecules for targeted cancer therapy.
    Wacheck V; Zangemeister-Wittke U
    Crit Rev Oncol Hematol; 2006 Jul; 59(1):65-73. PubMed ID: 16750913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antisense oligonucleotide-based therapeutics for cancer.
    Dean NM; Bennett CF
    Oncogene; 2003 Dec; 22(56):9087-96. PubMed ID: 14663487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA drug design for cancer therapy.
    Cho-Chung YS
    Curr Pharm Des; 2005; 11(22):2811-23. PubMed ID: 16101439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidermal growth factor receptor: a promising target in solid tumours.
    Laskin JJ; Sandler AB
    Cancer Treat Rev; 2004 Feb; 30(1):1-17. PubMed ID: 14766123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.